Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Eur J Pharmacol ; 710(1-3): 39-48, 2013 Jun 15.
Article in English | MEDLINE | ID: mdl-23588118

ABSTRACT

Acute lung injury is a life-threatening syndrome characterized by overwhelming lung inflammation and increased microvascular permeability, which causes a high mortality rate worldwide. The dry root of Peucedanum praeruptorum Dunn has been long used to treat respiratory diseases in China. In the present study, Praeruptorin A, C, D and E (PA, PC, PD and PE), four pyranocoumarins extracted from this herb, have been investigated for the pharmacological effects in experimental lung injury mouse models. In lipopolysaccharide (LPS) challenged mice, PA and PC did not show protective effect against lung injury at the dose of 80 mg/kg. However, PD and PE significantly inhibited the infiltration of activated polymorphonuclear leukocytes (PMNs) and decreased the levels of TNF-α and IL-6 in bronchoalveolar lavage fluid at the same dose. There was no statistically significant difference between PD and PE group. Further study demonstrated that PD and PE suppressed protein extravasations in bronchoalveolar lavage fluid, attenuated myeloperoxidase (MPO) activity and the pathological changes in the lung. Both PD and PE suppressed LPS induced Nuclear Factor-kappa B (NF-κB) pathway activation in the lung by decreasing the cytoplasmic loss of Inhibitor κB-α (IκB-α) protein and inhibiting the translocation of p65 from cytoplasm to nucleus. We also extended our study to acid-induced acute lung injury and found that these two compounds protected mice from hydrochloric acid (HCl)-induced lung injury by inhibiting PMNs influx, IL-6 release and protein exudation. Taken together, these results suggested that PD and PE might be useful in the therapy of lung injury.


Subject(s)
Acute Lung Injury/drug therapy , Anti-Inflammatory Agents/therapeutic use , Coumarins/therapeutic use , Acute Lung Injury/chemically induced , Acute Lung Injury/immunology , Acute Lung Injury/pathology , Animals , Anti-Inflammatory Agents/pharmacology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cell Count , Coumarins/pharmacology , Hydrochloric Acid , Interleukin-6/immunology , Lipopolysaccharides , Lung/drug effects , Lung/immunology , Lung/pathology , Male , Mice , Mice, Inbred BALB C , Peroxidase/immunology , Tumor Necrosis Factor-alpha/immunology
2.
Biol Pharm Bull ; 36(3): 399-406, 2013.
Article in English | MEDLINE | ID: mdl-23318249

ABSTRACT

Mollugin, a kind of naphthohydroquinone, is a major constituent isolated from Rubia cordifolia L. and demonstrated to possess anti-inflammatory activity in recent reports. However, the effects and mechanism of action of mollugin in inflammation have not been fully defined. The present study was therefore designed to investigate whether mollugin suppresses the inflammatory response in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Mollugin attenuated the LPS-induced expression of nitric oxide (NO), inducible nitric oxide synthase (iNOS), interleukin (IL)-1ß and IL-6 but augmented the expression of tumor necrosis factor (TNF)-α. Mollugin did not inhibit the degradation of inhibitory kappa B (IκB)-α or the nuclear translocation of p65 nuclear factor-kappa B (NF-κB) but rather enhanced the phosphorylation of p65 subunits evoked by LPS. Mollugin did not inhibit the phosphorylation of extracellular-signal-related kinase (ERK) 1/2, p38, and c-Jun N-terminal kinase (JNK) 1/2 either. Mollugin significantly reduced the LPS-mediated phosphorylation of Janus kinase (JAK) 2, signal transducers and activators of transcription (STAT) 1 and STAT3. Molecular docking analysis showed that mollugin binds to JAK2 in a manner similar to that of AG490, a specific JAK2 inhibitor. We conclude that mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Drugs, Chinese Herbal/pharmacology , Janus Kinase 2/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Pyrans/pharmacology , STAT1 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/antagonists & inhibitors , Animals , Cells, Cultured , Interleukin-1beta/biosynthesis , Interleukin-6/biosynthesis , Janus Kinase 2/metabolism , MAP Kinase Signaling System/drug effects , Macrophages/metabolism , Mice , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/metabolism
3.
Phytother Res ; 26(9): 1320-6, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22294521

ABSTRACT

Myrislignan is a new kind of lignan isolated from Myristica fragrans Houtt. Its antiinflammatory effects have not yet been reported. In the present study, the antiinflammatory effects and the underlying mechanisms of myrislignan in lipopolysaccharide (LPS)-induced inflammation in murine RAW 264.7 macrophage cells were investigated. Myrislignan significantly inhibited LPS-induced production of nitric oxide (NO) in a dose-dependent manner. It inhibited mRNA expression and release of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α). This compound significantly inhibited mRNA and protein expressions of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) dose-dependently in LPS-stimulated macrophage cells. Further study showed that myrislignan decreased the cytoplasmic loss of inhibitor κB-α (IκB-α) protein and the translocation of NF-κB from cytoplasm to the nucleus. Our results suggest that myrislignan may exert its antiinflammatory effects in LPS-stimulated macrophages cells by inhibiting the NF-κB signalling pathway activation.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Lignans/pharmacology , Macrophages/drug effects , NF-kappa B/metabolism , Signal Transduction/drug effects , Animals , Cell Line , Cyclooxygenase 2/metabolism , I-kappa B Proteins/metabolism , Inflammation/metabolism , Interleukin-6/metabolism , Lipopolysaccharides , Mice , NF-KappaB Inhibitor alpha , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Tumor Necrosis Factor-alpha/metabolism
4.
Inflammation ; 35(3): 967-77, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22083490

ABSTRACT

Praeruptorin C, D, and E (PC, PD, and PE) are three pyranocoumarins isolated from the dried root of Peucedanum praeruptorum Dunn of Umbelliferae. In the present study, we investigated the anti-inflammatory effect of these compounds in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells. Pyranocoumarins significantly inhibited LPS-induced production of nitric oxide, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). The mRNA and protein expressions of inducible nitric oxide synthase, IL-6, and TNF-α were also suppressed by these compounds. Both PD and PE exhibited greater anti-inflammatory activities than PC. Further study showed that pyranocoumarins suppressed the cytoplasmic loss of inhibitor κB-α protein and inhibited the translocation of NF-κB from cytoplasm to nucleus. In addition, pyranocoumarins suppressed LPS-induced STAT3 tyrosine phosphorylation. Taken together, the results suggest that pyranocoumarins may exert anti-inflammatory effects in LPS-stimulated RAW 264.7 macrophages through the inhibition of NF-κB and STAT3 activation.


Subject(s)
Inflammation/drug therapy , Macrophages/immunology , NF-kappa B/metabolism , Pyranocoumarins/pharmacology , STAT3 Transcription Factor/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Apiaceae , Cell Line , Coumarins/pharmacology , I-kappa B Kinase/metabolism , Inflammation Mediators , Interleukin-6/biosynthesis , Interleukin-6/genetics , Lipopolysaccharides/immunology , Macrophages/drug effects , Macrophages/pathology , Mice , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Phosphorylation/drug effects , Plant Extracts/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/drug effects , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
5.
Inflamm Res ; 60(9): 851-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21667204

ABSTRACT

OBJECTIVE AND DESIGN: The anti-inflammatory effect of methyl-1-hydroxy-2-naphthoate (MHNA), a novel naphthol derivative, was evaluated in the lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages. MATERIALS AND METHODS: The release of nitric oxide (NO), interleukin-1beta (IL-1ß) and interleukin-6 (IL-6) were detected by the Griess reagent and ELISA methods. The protein expressions of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) were examined by Western blotting. The mRNA expressions of IL-1ß, IL-6, iNOS and COX-2 were determined by real-time PCR. Activation of mitogen-activated protein kinases (MAPKs) and nuclear factor kappa B (NF-κB) pathways were detected by Western blotting, reporter gene assay and electrophoretic mobility shift assay. RESULTS: MHNA significantly inhibited the release of NO, IL-1ß and IL-6 as well as the protein expression of iNOS and COX-2 in LPS-stimulated macrophages. It also inhibited the mRNA expression of iNOS, COX-2, IL-1ß and IL-6. Further studies indicated that MHNA inhibited LPS-induced increases in NF-κB DNA-binding activity and NF-κB transcriptional activity as well as IκB-α degradation and NF-κB translocation in a dose-dependent manner. Meanwhile, the activation of p38 MAPK and c-Jun N-terminal kinases (JNK) induced by LPS were decreased by MHNA. CONCLUSIONS: MHNA inhibits the LPS-induced inflammatory response in murine macrophages via suppression of NF-κB and MAPKs signaling pathways activation.


Subject(s)
Inflammation/chemically induced , JNK Mitogen-Activated Protein Kinases/metabolism , Lipopolysaccharides/pharmacology , Macrophages/drug effects , NF-kappa B/metabolism , Naphthols/pharmacology , Signal Transduction/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Cell Line , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Humans , I-kappa B Proteins/metabolism , Inflammation/immunology , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Lipopolysaccharides/immunology , Macrophages/cytology , Macrophages/immunology , Mice , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Molecular Structure , NF-KappaB Inhibitor alpha , NF-kappa B/genetics , Naphthols/chemistry , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Signal Transduction/immunology
6.
Phytother Res ; 25(4): 550-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20842678

ABSTRACT

Praeruptorin A (PA) is a pyranocoumarin compound isolated from the dried root of Peucedanum praeruptorum Dunn (Umbelliferae). However, the antiinflammatory effect of PA has not been reported. The present study investigated the antiinflammatory effect of PA in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. PA significantly inhibited the LPS-induced production of nitric oxide (NO), interleukin-1ß (IL-1ß) and tumor necrosis factor-α (TNF-α). The mRNA and protein expressions of inducible nitric oxide synthase (iNOS), IL-1ß and TNF-α were also suppressed by this compound. Further study showed that PA decreased the cytoplasmic loss of inhibitor κB-α (IκB-α) protein and inhibited the translocation of NF-κB from cytoplasm to nucleus. Taken together, the results suggest that PA may exert antiinflammatory effects in vitro in LPS-stimulated RAW 264.7 macrophages through inhibition of NF-κB signal pathway activation.


Subject(s)
Coumarins/pharmacology , Inflammation/prevention & control , Lipopolysaccharides/pharmacology , Macrophages/drug effects , NF-kappa B/antagonists & inhibitors , Animals , Base Sequence , Blotting, Western , Cell Line , DNA Primers , Fluorescent Antibody Technique , Inflammation/metabolism , Interleukin-1/genetics , Interleukin-1/metabolism , Macrophages/metabolism , Macrophages/pathology , Mice , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Polymerase Chain Reaction , RNA, Messenger/genetics , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
7.
Acta Pharmacol Sin ; 31(8): 953-62, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20686520

ABSTRACT

AIM: To investigate whether geniposide, an iridoid glucoside extracted from gardenia jasminoides ellis fruits, inhibits cell adhesion to human umbilical vein endothelial cells (HUVECs) induced by high glucose and its underlying mechanisms. METHODS: HUVECs were isolated from human umbilical cords and cultured. The adhesion of monocytes to HUVECs was determined using fluorescence-labeled monocytes. The mRNA and protein levels of vascular cell adhesion molecule-1 (VCAM-1) and endothelial selectin (E-selectin) were measured using real-time RT-PCR and ELISA. Reactive oxygen species (ROS) production was measured using a fluorescent probe. The amounts of nuclear factor-kappa B (NF-kappaB) and inhibitory factor of NF-kappaB (IkappaB) were determined using Western blot analysis. The translocation of NF-kappaB from the cytoplasm to the nucleus was determined using immunofluorescence. RESULTS: Geniposide (10-20 mumol/L) inhibited high glucose (33 mmol/L)-induced adhesion of monocytes to HUVECs in a dose-dependent manner. This compound (5-40 mumol/L) also inhibited high glucose-induced expression of VCAM-1 and E-selectin at the gene and protein levels. Furthermore, geniposide (5-20 micromol/L) decreased ROS production and prevented IkappaB degradation in the cytoplasm and NF-kappaB translocation from the cytoplasm to the nucleus in HUVECs. CONCLUSION: Geniposide inhibits the adhesion of monocytes to HUVECs and the expression of CAMs induced by high glucose, suggesting that the compound may represent a new treatment for diabetic vascular injury. The mechanism underlying this inhibitory effect may be related to the inhibition of ROS overproduction and NF-kappaB signaling pathway activation by geniposide.


Subject(s)
Gardenia/chemistry , Iridoids/pharmacology , NF-kappa B/metabolism , Cell Adhesion , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Glucose/pharmacology , Humans , Iridoids/administration & dosage , Iridoids/isolation & purification , Monocytes/drug effects , Monocytes/metabolism , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Umbilical Veins/drug effects , Umbilical Veins/metabolism
8.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(12): 2473-6, 2009 Dec.
Article in Chinese | MEDLINE | ID: mdl-20034905

ABSTRACT

OBJECTIVE: To establish a mouse model of humoral immune response by immunization with rabbit red blood cells (RRBCs). METHODS: The mice were immunized with RRBCs and the serum hemolysin level was measured by micro-hemolysis spectrophotometry. RESULTS: The peak time needed for hemolysin production against RRBCs was 6 days after the immunization, and 20% RRBCs in a total volume of 0.2 ml was optimal for intraperitoneal injection. Hydrocortisone (25 mg/kg) and cyclophosphamide (20 mg/kg) inhibited hemolysin production. Mannatide (4 mg/kg) produced no significant effect on serum hemolysin level in normal mice, but significantly potentiated hemolysin production in immunosuppressed mice induced by cyclophosphamide (20 mg/kg). CONCLUSION: Intraperitoneal RRBC injection is feasible for establishing mouse models of humoral immune response.


Subject(s)
Erythrocytes/immunology , Immunity, Humoral , Mice/immunology , Models, Animal , Animals , Female , Guinea Pigs , Hemolysin Proteins/blood , Immunization , Male , Rabbits
9.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(10): 2133-4, 2137, 2009 Oct.
Article in Chinese | MEDLINE | ID: mdl-19861284

ABSTRACT

OBJECTIVE: To observe the effects of lipopolysaccharides of Bacterium prodigiosum (BP-LPS) in inhibiting tumor growth and improving immunosuppression in mice. METHODS: In mice bearing S180 tumor and a mouse model of immunosuppression induced by cyclophosphamide (CTX), the tumor growth, indexes of the immune organs and peripheral white blood cell count were measured after intraperitoneal injection of BP-LPS. RESULTS: Injections of BP-LPS (40 U/kg) for 8 consecutive days resulted in a significant inhibition of the tumor growth in mice bearing S180 tumor (P<0.01), with a dose-dependent increase of the spleen indexes but no obvious changes in the thymus indexes. Intraperitoneal injections of BP-LPS for 7 days inhibited the reduction of peripheral white blood cells and spleen indexes in immunosuppressive mice, but did not produce any significant changes in normal mice. CONCLUSION: BP-LPS can inhibit the tumor growth in tumor-bearing mice and enhance the immune functions of immunosuppressive mice.


Subject(s)
Antineoplastic Agents/pharmacology , Immunosuppressive Agents/pharmacology , Polysaccharides, Bacterial/pharmacology , Serratia/chemistry , Animals , Female , Lipopolysaccharides/isolation & purification , Lipopolysaccharides/pharmacology , Male , Mice , Polysaccharides, Bacterial/isolation & purification , Random Allocation
10.
Zhong Yao Cai ; 32(4): 561-3, 2009 Apr.
Article in Chinese | MEDLINE | ID: mdl-19645242

ABSTRACT

OBJECTIVE: To study the effect of Flammulina velutipes polysaccharides (FVP) on the production of tumor necrosis factor alpha (TNF-alpha), interferon-gamma (INF-gamma) and interleukin 2 (IL-2) by murine immunocytes. METHODS: The cell's metabolic activity was determined with methylthiazolyl tetrazolium (MTT) colorimetry assay and the amounts of TNF-alpha, INF-gamma and IL-2 were measured by ELISA. RESULTS: FVP (200, 100, 50 microg/mL) could promote the metabolic activity of murine splenocytes and peritoneal exudate cells (PEC) and increase the amounts of TNF-alpha, INF-gamma and IL-2 in the supernatants of splenocyte cultures, and the amount of TNF-alpha in PEC cultures, with the most marked increase on TNF-alpha level. FVP (100, 50, 25 mg/kg) could raise the serum levels of TNF-alpha and INF-gamma in S180 tumor-bearing mice. CONCLUSION: FVP may regulate murine immune function through promoting the production of TNF-alpha, INF-gamma and IL-2.


Subject(s)
Agaricales/chemistry , Cytokines/metabolism , Polysaccharides/pharmacology , Sarcoma 180/blood , Spleen/drug effects , Animals , Cells, Cultured , Cytokines/blood , Enzyme-Linked Immunosorbent Assay , Female , Interferon-gamma/biosynthesis , Interferon-gamma/blood , Interleukin-2/biosynthesis , Male , Mice , Mice, Inbred BALB C , Peritoneum/cytology , Peritoneum/drug effects , Peritoneum/metabolism , Polysaccharides/administration & dosage , Random Allocation , Sarcoma 180/pathology , Spleen/cytology , Spleen/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/blood
11.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(3): 458-61, 2009 Mar.
Article in Chinese | MEDLINE | ID: mdl-19304524

ABSTRACT

OBJECTIVE: To investigate the immunomodulatory effects of Fomes fomentarius polysaccharides (FFP) in mice. METHODS: MTT assay was employed to evaluate the in vitro metabolic activity of the mouse splenocytes treated with FFP at different concentrations, and the secretion of tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (INF-gamma) and interleukin 2 (IL-2) from the cells were measured by enzyme-linked immunosorbent assay. The changes in the phagocytotic activity of mouse macrophage in response to FFP treatment were evaluated by phagocytosis percentage of chicken red blood cells (CRBCs). The effect of FFP on the humoral immunity was assessed in mice immunized with sheep red blood cells (SRBCs) by measuring the serum levels of specific antibody (hemolysin) against SRBCs. RESULTS: FFP at the concentrations of 25, 50, and 100 microg/ml all significantly enhanced the metabolic activity of mouse splenocytes in vitro and increased the production of TNF-alpha, IFN-gamma and IL-2. FFP treatment also markedly enhanced the metabolic activity of mouse peritoneal exudate cells and TNF-alpha production by the cells. At the doses of 25, 50, and 100 mg/kg, FFP significantly increased serum hemolysin level in mice immunized with SRBCs, and FFP at 50 and 100 mg/kg obviously increased the capacity of mouse peritoneal macrophages in vivo for CRBC phagocytosis. CONCLUSION: FFP can promote the secretion of TNF-alpha, IFN-gamma and IL-2 by mouse immunocytes and enhance mouse humoral immune response and the phagocytotic activity of the macrophages.


Subject(s)
Adjuvants, Immunologic/pharmacology , Coriolaceae/chemistry , Macrophages, Peritoneal/immunology , Polysaccharides/pharmacology , Animals , Female , Immunologic Factors/immunology , Immunologic Factors/pharmacology , Interferon-gamma/metabolism , Interleukin-2/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Male , Mice , Mice, Inbred BALB C , Phagocytosis/drug effects , Polysaccharides/isolation & purification , Tumor Necrosis Factor-alpha/metabolism
12.
Nan Fang Yi Ke Da Xue Xue Bao ; 28(1): 132-3, 2008 Jan.
Article in Chinese | MEDLINE | ID: mdl-18227045

ABSTRACT

OBJECTIVE: To explore the dynamic changes of blood sugar and body's signs in streptozotocin diabetic animal models. METHODS: Rat and mouse diabetic models were established by a single intraperitoneal (ip) injection and 5-day successive ip injections of streptozotocin respectively. Blood sugar levels were measured. The food consumption index (consumption of food/body weight) and the water consumption index (consumption of water/body weight) were calculated. RESULTS: Sixty five point zero percent male rats received streptozotocin, 60 mg/kg ip, developed diabetes mellitus. The blood sugar remained in high level between the 15th day and the 25th day after injection, and it began to decline afterwards. By 5-day ip injections of streptozotocin, 40 mg/kg daily, 90.0% male mice developed diabetes mellitus. Dynamic changes of blood sugar of diabetic mouse were similar to those of rats, except that the blood sugar of mice did not decline as obvious as that of rats. The changes of water consumption index were in best fit with the changes of blood sugar in both models, with correlation index r>0.970. CONCLUSION: The blood sugar of diabetic animal model stayed in high level from the 15th day to the 25th day after the beginning of injection. And the period is suitable for observing effect of anti-diabetic drugs. The water consumption index can reflect the blood sugar levels of diabetes animals.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/physiopathology , Disease Models, Animal , Animals , Body Weight/physiology , Diabetes Mellitus, Experimental/chemically induced , Drinking/physiology , Eating/physiology , Male , Mice , Rats , Rats, Wistar , Streptozocin
13.
Zhong Yao Cai ; 30(8): 909-11, 2007 Aug.
Article in Chinese | MEDLINE | ID: mdl-18074833

ABSTRACT

OBJECTIVE: To study the anticoagulant activity of different portions of leech ethanol extracts (LEEs). METHODS: Anticoagulant activity was determined by measuring prothrombin time(PT), thrombin time (TT), activated partial throboplstin time (APTT) and fibrinogen coagulation time (FCT). RESULTS: PT, TT, APTT and FCT were remarkably prolonged by ethyl acetate portion of LEEs. Portions of petroleum ethrer, n-butanol and water extracted from LEEs was much weaker on anticoagulant activity. CONCLUSION: The anticoagulant effect of ethyl acetate extract portion of LEEs is the strongest among the four portions, and this results may be from its inhibitory effect on thrombin-catalyzed fibrinogen hydrolysis.


Subject(s)
Anticoagulants/pharmacology , Blood Coagulation/drug effects , Leeches/chemistry , Materia Medica/pharmacology , Animals , Anticoagulants/isolation & purification , Blood Coagulation Tests , Ethanol , Humans , Materia Medica/isolation & purification , Partial Thromboplastin Time , Prothrombin Time , Thrombin Time
14.
Nan Fang Yi Ke Da Xue Xue Bao ; 27(7): 1003-5, 2007 Jul.
Article in Chinese | MEDLINE | ID: mdl-17666337

ABSTRACT

OBJECTIVE: To investigate the effect of Ganoderma lucidum polysaccharides (GLP) on the nucleotide contents and cell cycle distribution of the tumor cells in S180 ascitic tumor-bearing mice and explore the possible mechanism of the antitumor effect of GLP. METHODS: Mice bearing S180 ascitic tumor were subjected to intragastric administration of GLP (100, 200, and 400 mg/kg), normal saline or subcutaneous injection of cyclophosphamide (CTX) at 25 mg/kg, respectively. The treatment was given once daily for 9 consecutive days, after which the ascitic tumor cells were harvested for determination of the RNA and DNA contents and their ratio as well as the cell cycle alterations. Laser scanning confocal microscopy and acridine orange staining was performed to evaluate the DNA and RNA fluorescence intensity, and flow cytometry with propidium iodide (PI) staining was utilized for cell cycle analysis of the tumor cells. RESULTS: Compared with normal saline group, the tumor cells in the 3 GLP groups all showed reduced RNA and DNA contents, and this reduction was statistically significant in 200 mg/kg GLP group (P=0.000). Significantly reduced RNA/DNA ratio was noted in all the 3 GLP groups (P=0.003, 0.000, 0.008 corresponding to 400, 200, and 100 mg/kg groups), suggesting that ganoderma polysaccharides more effectively reduced RNA content than DNA content. CTX also resulted in reduced RNA and DNA contents but not the RNA/DNA ratio. At the doses of 400, 200, and 100 mg/kg, GLP increased the percentage of G2/G2 phase cells (P=0.003, 0.000, and 0.000) whereas CTX showed the contrary effect (P=0.000). GLP produced no obvious effect on S-phage cells but CTX significantly reduced their percentage (P=0.000). GLP at the 3 doses all decreased the percentage of G2/M phase tumor cells (P=0.014, 0.049, 0.016) and CTX again induced contrary effect (P=0.000). CONCLUSION: With different effects from CTX on DNA and RNA contents and cell cycle, GLP inhibits DNA and RNA synthesis in the tumor cells by mobilizing the host immune function to interfere with the normal cell cycles, which might be one of the mechanisms for the antitumor effect of GLP.


Subject(s)
Ascitic Fluid , Cell Cycle/drug effects , DNA/metabolism , Polysaccharides/pharmacology , RNA/metabolism , Reishi/chemistry , Sarcoma 180/genetics , Sarcoma 180/pathology , Animals , Antineoplastic Agents/pharmacology , Cell Line, Tumor , DNA/drug effects , Dose-Response Relationship, Drug , Immunohistochemistry , Male , Mice , RNA/drug effects , Xenograft Model Antitumor Assays
15.
Nan Fang Yi Ke Da Xue Xue Bao ; 27(2): 188-90, 194, 2007 Feb.
Article in Chinese | MEDLINE | ID: mdl-17355933

ABSTRACT

OBJECTIVE: To study the antitumor effect of saponin extracted from Tupistra chinensis Baker (STCB) against mouse sarcoma S-180 cell proliferation in vitro and in vivo and explore the primary mechanism of this effect. METHODS: Cytotoxic effect of STCB on S-180 cells in vitro was evaluated by MTT colorimetry, and its effect against in vitro tumor growth was tested in Kunmin mice bearing S-180 implanted tumor. The morphological and ultrastructural changes of S-180 cells after saponin treatment in vitro were examined with light and transmission electron microscope. Flow cytometry was performed to examine the cell cycle and apoptosis of S180 cells treated with different concentrations of STCB with propidium iodide staining. RESULTS: STCB could markedly inhibit S-180 cell proliferation in vitro with 50% inhibitory concentration of 34.64 microg/ml. STCB given by intragastric administration also significantly inhibited the growth of S-180 solid tumor, and the inhibition rate exceeded 30% at the dose of 0.5 g/kg, reaching 54.86% at 2 g/kg. Electron microscopy and flow cytometry revealed increased S180 tumor cell apoptotic rate with the increment of saponin concentration, along with increased percentage of cells in S phase and decreased cells in G(2)/M phase in response to 10 or 30 microg/ml STCB treatment. At the concentration of 60 microg/ml, however, STCB resulted in an opposite effect on the cell cycles, presumably due to its interference with mitosis at high concentrations. CONCLUSIONS: STCB inhibits the growth of S-180 cells both in vivo and in vitro possibly by inducing cell apoptosis and interfering with the cell cycle progression of the tumor cells.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cell Proliferation/drug effects , Liliaceae/chemistry , Saponins/pharmacology , Sarcoma 180/drug therapy , Animals , Antineoplastic Agents, Phytogenic/therapeutic use , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Line, Tumor , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Male , Mice , Phytotherapy , Saponins/therapeutic use , Sarcoma 180/pathology
16.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(6): 780-3, 2006 Jun.
Article in Chinese | MEDLINE | ID: mdl-16793600

ABSTRACT

OBJECTIVE: To determine if Ganoderma polysaccharides can antagonize prostaglandin E2 (PGE2)-induced suppression of murine splenocyte interferongamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) mRNA expression. METHODS: Mixed lymphocyte culture reaction was used as the experimental model. The expressions levels of IFN-gamma and TNF-alpha mRNA were measured by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: After the cultures were treated with PGE2 for 4 h, IFN-gamma mRNA expression was reduced as compared with the control, which was especially obvious when PGE2 concentrations exceeded 10 micromol/L (P<0.01). Ganoderma polysaccharides above 100 mg/L showed partial antagonistic effect against the inhibition of IFN-gamma by PGE2 at the fixed concentration of 20 micromol/L. Further studies indicated that PGE2 (20 micromol/L) impaired the expression of TNF-alpha mRNA after an 8-hour incubation and Ganoderma polysaccharides above 100 mg/L could partially antagonize this effect. CONCLUSION: Ganoderma polysaccharides can partially antagonize PGE2-induced suppression of murine splenocyte IFN-gamma and TNF-alpha mRNA expression.


Subject(s)
Dinoprostone/pharmacology , Interferon-gamma/genetics , Polysaccharides/pharmacology , Reishi/chemistry , Tumor Necrosis Factor-alpha/genetics , Animals , Cells, Cultured , Female , Gene Expression/drug effects , Lymphocytes/cytology , Lymphocytes/drug effects , Lymphocytes/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Spleen/cytology
17.
Di Yi Jun Yi Da Xue Xue Bao ; 25(3): 251-4, 2005 Mar.
Article in Chinese | MEDLINE | ID: mdl-15771985

ABSTRACT

OBJECTIVE: To isolate and purify a new polysaccharid Streptomyces polysaccharid polysaccharide (SMP ), from cultured broth of a Streptomyces sp.strain and perform its structural analysis. METHODS: Ethanol was used to precipitate the polysaccharides and macromolecules from the broth. The proteins in the precipitate were removed by Sevage method and purification of SMP was carried out by DEAE-celluloseion-exchange chromatography and Sephadex G-25 gel filtration. The chemical structure of the SMP was determined by combined application of high performance liquid chromatography (HPLC), UV, IR and 1H-NMR spectroscopy, supplemented by periodate oxidation and Smith degradation. RESULTS: The purified SMP was neutral by a relative molecular mass of approximately 4 855. Sugar analysis showed that SMP contained glucose and fructose residues in an approximate molar ratio of 22:1 (10.96 to 0.48). The glycosidic linkages were estimated to be (1-6)- alpha-D- pyranoside form. CONCLUSION: SMP is characterized as a (1-6)- alpha-D- pyranose.


Subject(s)
Polysaccharides, Bacterial/chemistry , Polysaccharides, Bacterial/isolation & purification , Streptomyces/chemistry , Soil/analysis
18.
Di Yi Jun Yi Da Xue Xue Bao ; 24(7): 836-8, 2004 Jul.
Article in Chinese | MEDLINE | ID: mdl-15257920

ABSTRACT

OBJECTIVE: To isolate and identify an anticoagulation factor, acoagulatin, from the venom of Chinese Agkistrodon and to observe its anticoagulation effect. METHOD: The venom of Chinese Agkistrodon was isolated and purified using ion-exchange chromatography on DEAE-Sepharose Fast Flow and CM-sepharose Fast Flow. High-performance liquid chromatography (HPLC) was performed for determination of the purity of acoagulatin, and SDS-PAGE electrophoresis (with 5% concentrated gel of pH 6.8, 12% separation gel of pH 8.8, Tris-aminoacetic acid buffer of pH 8.3 as the electrode buffer) for determining the relative molecular mass. For observation of the anticoagulation effect, 20 microl acoagulatin solution at the concentration of 0.30, 0.20 and 0.15 microg/microl, respectively, was mixed with 100 microl rabbit anticoagulated plasma and the thrombin time (TT), prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined. RESULTS: Acoagulatin was found to consist of two subunits with relative molecular mass of 14 400 and 17 000 respectively, resulting in the total relative molecular mass of 31 400 as determined by SDS-PAGE. HPLC demonstrated good homogeneity of this protein, which significantly prolonged the PT and APTT without affecting TT. CONCLUSION: DEAE-Sepharose Fast Flow and CM-sepharose Fast Flow ion exchange column chromatographies are effective to isolate acoagulatin of high purity, which possesses anticoagulation effect.


Subject(s)
Anticoagulants/isolation & purification , Crotalid Venoms/analysis , Animals , Anticoagulants/pharmacology , Male , Partial Thromboplastin Time , Prothrombin Time , Rabbits
19.
Di Yi Jun Yi Da Xue Xue Bao ; 21(11): 819-821, 2001.
Article in English | MEDLINE | ID: mdl-12426180

ABSTRACT

OBJECTIVE: To study the effect of E1B mutant adenovirus (dl1520) on 3 p53-deficient leukemic cell lines K562, Jurkat and HL-60. METHODS: The replication efficiency of dl1520 in the 3 leukemic cell lines was assessed by plaque assay, and the number of cells killed by the adenovirus determined by using trypan-blue in a course of 10 d following the infection. RESULTS: The replication efficiency of dl1520 in the 3 leukemic cell lines was significantly lower than that in the positive control, and no significant cytocidal effect against the 3 cell lines was observed. CONCLUSION: dl1520 can not inhibit the malignant blood cells as K562, Jurkat and HL-60 cell lines.

SELECTION OF CITATIONS
SEARCH DETAIL